When your look at the contributions made my Mikhail Blagosklonny, it is hard not to realize he is someone special. With years of expertise under his belt, Mikhail Blagosklonny has made the world a better place. This is true. Behind the scenes, Mikhail Blagosklonny has been transforming the world of Oncology. This is something you cannot take from him. By tirelessly researching and studying cancer treatment, Mikhail Blagosklonny has made significant progress. Thousands of cancer patients have benefited from his bodies of work. Aside from decades of research, Mikhail Blagosklonny still has the time to teach at Roswell Park Cancer institute.
Can you guess what he teaches? He is an oncology professor. As a professor, Blagosklonny breaks down cancer research from some of the world’s brightest minds. In addition, Mikhail Blagosklonny’s discussions entail information found in Oncotarget. Oncotarget is a publication he created. Also, his peers have the ability to make contributions and review the work found in his publication. With that being said, Mikhail Blagosklonny comes from an educated background. In fact, Mikhail Blagosklonny graduated from First Pavlov. First Pavlov State Medical University is located in St. Petersburg. While there, he obtained his M.D. in medicine. Blagosklonny’s educational background is nothing short of impressive. In addition to a M.D. in medicine, he also earned a PhD in the area of cardiology. View Mikhail’s profile in LinkedIn
One area near and dear to Mikhail Blagosklonny are the illnesses related to the the aging process. In particular, this is an area where Mikhail seeks to make the biggest impact. Based on his research, Mikhail Blagosklonny believes that isolated cancer treatment is more effective in protecting normal cells in the human body. In addition, Mikhail is an avid supporter of the drug rapamycin. Throughout his research, Mikhail discovered the potency of using rapamycin in extending the lives of many cancer patients. It is an area of cancer research where Mikhail Blagosklonny never falls short. Time and time again, he has delivered high quality work. As a result, he has been an asset to the cancer research community and ultimately the rest of the world. Follow Mikhail on Loop